Development of a new patient‐reported outcome measure to assess activities and participation in people with systemic sclerosis: the Cochin 17‐item Scleroderma Functional scale
Authors:
- 4 February 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 183 (4) , 710-718
Abstract
Objectives To develop a new patient‐reported outcome measure assessing activities and participation in people with systemic sclerosis (SSc). Methods A provisional International Classification of Functioning, Disability and Health (ICF)‐based 65‐item questionnaire previously developed from interviews of people with SSc was sent by email to all patients followed in the internal medicine department of Cochin hospital (n=184) and enrolled in the Scleroderma Patient‐centered Intervention Network Cohort. Items were reduced according to their metric properties. Dimensional structure of the questionnaire was assessed by principal component analysis, convergent and divergent validities by the Spearman correlation coefficient (ρ), internal consistency by the Cronbach α coefficient, and reliability by a test‐retest method using intraclass correlation coefficient (ICC) and Bland and Altman analysis. Results Overall, 113/184 (61.4%) patients completed the provisional questionnaire. The item‐reduction process resulted in a 17‐item questionnaire, the Cochin 17‐item Scleroderma Functional scale (CSF‐17). Principal component analysis extracted 2 dimensions: 10 items related to mobility (CSF‐17 section A) and 7 items related to general tasks (CSF‐17 section B). We observed convergent validity of the CSF‐17 total score with global activity limitation, pain, depression and aesthetic burden, and divergent validity with anxiety. The Cronbach α coefficient was 0.94 for section A and 0.95 for section B. ICC (n=25 patients) was 0.92 for CSF‐17 total score. Bland and Altman analysis did not reveal a systematic trend for the test‐retest. Conclusions The CSF‐17 is a new patient‐reported outcome assessing activities and participation specifically in people with SSc. Its content and construct validities are very good.Keywords
This publication has 43 references indexed in Scilit:
- The Scleroderma Patient-centered Intervention Network (SPIN) Cohort: protocol for a cohort multiple randomised controlled trial (cmRCT) design to support trials of psychosocial and rehabilitation interventions in a rare disease contextBMJ Open, 2013
- The Symptom Burden Index: Development and Initial Findings from Use with Patients with Systemic SclerosisThe Journal of Rheumatology, 2010
- Reliability and validity of the university of california, los angeles scleroderma clinical trial consortium gastrointestinal tract instrumentArthritis Care & Research, 2009
- Patient preference disability questionnaire in systemic sclerosis: A cross‐sectional surveyArthritis Care & Research, 2008
- Development and validation of a scale for mouth handicap in systemic sclerosis: the Mouth Handicap in Systemic Sclerosis scaleAnnals of the Rheumatic Diseases, 2007
- ICF linking rules: an update based on lessons learnedJournal of Rehabilitation Medicine, 2005
- Improving the Quality of Web Surveys: The Checklist for Reporting Results of Internet E-Surveys (CHERRIES)Journal of Medical Internet Research, 2004
- Validating the SF-36 health survey questionnaire: new outcome measure for primary care.BMJ, 1992
- STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENTThe Lancet, 1986
- The Scree Test For The Number Of FactorsMultivariate Behavioral Research, 1966